Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)

Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic... Ann Hematol (2017) 96:1577–1578 DOI 10.1007/s00277-017-3039-1 LETTER TO THE EDITOR Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p) 1 1 1 Marcelo Pitombeira de Lacerda & Nayara Ribeiro Guedes & Patricia Eiko Yamakawa & 1 1 Andre Domingues Pereira & Ana Rita Brito Medeiros da Fonseca & 1 1 Maria Lourdes Lopes Ferrari de Chauffaille & Matheus Vescovi Goncalves & 1 1 Mihoko Yamamoto & Celso Arrais Rodrigues Received: 7 May 2017 /Accepted: 26 May 2017 /Published online: 9 June 2017 Springer-Verlag Berlin Heidelberg 2017 Dear editor, weeks. After 3 months, he showed improvement of symptoms We present the case of a 68-year-old male with chronic lym- and sustained hemoglobin levels, with no transfusion require- phocytic leukemia (CLL). He was diagnosed with CLL in ment. His latest flow cytometry study showed 0.05% CLL September 2007 and del (17p) was detected by FISH. In cells in peripheral blood. No CMV reactivation occurred. 2008, due to progressive splenomegaly, he received six cycles Two episodes of neutropenia were observed, without fever of fludarabine and cyclophosphamide and achieved complete or documented infection, responding to venetoclax interrup- response. In July 2015, he relapsed with progressive lympho- tion http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Hematology Springer Journals

Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)

Loading next page...
 
/lp/springer_journal/treatment-of-refractory-autoimmune-hemolytic-anemia-with-venetoclax-in-pZDWu8Eeca
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Hematology; Oncology
ISSN
0939-5555
eISSN
1432-0584
D.O.I.
10.1007/s00277-017-3039-1
Publisher site
See Article on Publisher Site

Abstract

Ann Hematol (2017) 96:1577–1578 DOI 10.1007/s00277-017-3039-1 LETTER TO THE EDITOR Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p) 1 1 1 Marcelo Pitombeira de Lacerda & Nayara Ribeiro Guedes & Patricia Eiko Yamakawa & 1 1 Andre Domingues Pereira & Ana Rita Brito Medeiros da Fonseca & 1 1 Maria Lourdes Lopes Ferrari de Chauffaille & Matheus Vescovi Goncalves & 1 1 Mihoko Yamamoto & Celso Arrais Rodrigues Received: 7 May 2017 /Accepted: 26 May 2017 /Published online: 9 June 2017 Springer-Verlag Berlin Heidelberg 2017 Dear editor, weeks. After 3 months, he showed improvement of symptoms We present the case of a 68-year-old male with chronic lym- and sustained hemoglobin levels, with no transfusion require- phocytic leukemia (CLL). He was diagnosed with CLL in ment. His latest flow cytometry study showed 0.05% CLL September 2007 and del (17p) was detected by FISH. In cells in peripheral blood. No CMV reactivation occurred. 2008, due to progressive splenomegaly, he received six cycles Two episodes of neutropenia were observed, without fever of fludarabine and cyclophosphamide and achieved complete or documented infection, responding to venetoclax interrup- response. In July 2015, he relapsed with progressive lympho- tion

Journal

Annals of HematologySpringer Journals

Published: Jun 9, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off